Sinusitis Drug Pipeline Analysis 2024: By Clinical Trial Phase: Late-Stage Products (Phase III and Phase IV), Mid-Stage Products (Phase II), Early-Stage Products (Phase I), Preclinical and Discovery Stage Products; By Molecule Type: Antibody, Antisense Oligonucleotides, Immunotherapy, Monoclonal Antibody, Peptides, Protein, Recombinant Protein, Small Molecule, Stem Cell, Vaccine; Route Of Administration; Drug Profile; Key Players

Corporate License

$ 4499.00